MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01912-07v1
28/12/4204    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Woiwode, A.
Right arrow Articles by Johnson, D. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woiwode, A.
Right arrow Articles by Johnson, D. L.

 Previous Article

Molecular and Cellular Biology, June 2008, p. 4204-4214, Vol. 28, No. 12
0270-7306/08/$08.00+0     doi:10.1128/MCB.01912-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

PTEN Represses RNA Polymerase III-Dependent Transcription by Targeting the TFIIIB Complex{triangledown}

Annette Woiwode,1 Sandra A. S. Johnson,1 Shuping Zhong,1 Cheng Zhang,1 Robert G. Roeder,2 Martin Teichmann,3 and Deborah L. Johnson1*

Department of Biochemistry and Molecular Biology, University of Southern California, Keck School of Medicine and the Norris Comprehensive Cancer Center, Los Angeles, California 90033,1 Rockefeller University, New York, New York 10065,2 Institut Européen de Chimie et Biologie, Université Bordeaux 2 Victor Ségalen, Pessac F-33607, France3

Received 23 October 2007/ Returned for modification 2 January 2008/ Accepted 25 March 2008

PTEN, a tumor suppressor whose function is frequently lost in human cancers, possesses a lipid phosphatase activity that represses phosphatidylinositol 3-kinase (PI3K) signaling, controlling cell growth, proliferation, and survival. The potential for PTEN to regulate the synthesis of RNA polymerase (Pol) III transcription products, including tRNAs and 5S rRNAs, was evaluated. The expression of PTEN in PTEN-deficient cells repressed RNA Pol III transcription, whereas decreased PTEN expression enhanced transcription. Transcription repression by PTEN was uncoupled from PTEN-mediated effects on the cell cycle and was independent of p53. PTEN acts through its lipid phosphatase activity, inhibiting the PI3K/Akt/mTOR/S6K pathway to decrease transcription. PTEN, through the inactivation of mTOR, targets the TFIIIB complex, disrupting the association between TATA-binding protein and Brf1. Kinetic analysis revealed that PTEN initially induces a decrease in the serine phosphorylation of Brf1, leading to a selective reduction in the occupancy of all TFIIIB subunits on tRNALeu genes, whereas prolonged PTEN expression results in the enhanced serine phosphorylation of Bdp1. Together, these results demonstrate a new class of genes regulated by PTEN through its ability to repress the activation of PI3K/Akt/mTOR/S6K signaling.

* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, University of Southern California, Keck School of Medicine and the Norris Comprehensive Cancer Center, 2011 Zonal Avenue, Los Angeles, CA 90033. Phone: (323) 442-1446. Fax: (323) 442-1224. E-mail: johnsond{at}usc.edu

{triangledown} Published ahead of print on 7 April 2008.

Molecular and Cellular Biology, June 2008, p. 4204-4214, Vol. 28, No. 12
0270-7306/08/$08.00+0     doi:10.1128/MCB.01912-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.